Product image of Bendamustin Onkovis (Bendamustine Hydrochloride) supplied by GNH India

Bendamustin Onkovis

Active Ingredient:
Bendamustine Hydrochloride
Origin:
EU

Bendamustin Onkovis (Bendamustine Hydrochloride)

Bendamustin Onkovis is a pharmaceutical product containing Bendamustine Hydrochloride, used for intravenous administration. It is indicated for certain cancer treatments and is manufactured by Onkovis GmbH in the EU.

Manufacturer / TM Owner

Onkovis Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Bendamustin Onkovis is primarily used in the treatment of various types of cancer. It works by interfering with the growth and spread of cancer cells. Patients often wonder, 'What is Bendamustine Hydrochloride used for?' It is typically prescribed for conditions where chemotherapy is required, such as certain types of leukemia and lymphoma.

Side Effects

  • Common effects of Bendamustin Onkovis may include nausea, fatigue, and a lowered immune response. Some patients may experience hair loss or changes in blood cell counts. These effects can vary widely among individuals and should be discussed with a healthcare provider.

Precautions & Warnings

  • Bendamustin Onkovis should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should be monitored regularly for any adverse reactions.

Avoid Interactions

  • Bendamustin Onkovis may interact with other medications, including those that suppress the immune system or affect blood cell production. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of the treatment.

Frequently Asked Questions

Bendamustin Onkovis is used in the treatment of certain types of cancer, including leukemia and lymphoma.

Bendamustin Onkovis is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional.

Common side effects may include nausea, fatigue, and a lowered immune response. Some patients may also experience hair loss.

It is important to consult with a healthcare provider before taking Bendamustin Onkovis with other medications, as interactions can occur.

Bendamustin Onkovis is manufactured by Onkovis GmbH in the EU.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bendamustine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT